Literature DB >> 18403058

Novel imidazo[1,2-a]naphthyridinic systems (part 1): synthesis, antiproliferative and DNA-intercalating activities.

Mounir Andaloussi1, Emmanuel Moreau, Nicolas Masurier, Jacques Lacroix, René C Gaudreault, Jean-Michel Chezal, Anas El Laghdach, Damien Canitrot, Eric Debiton, Jean-Claude Teulade, Olivier Chavignon.   

Abstract

Novel imidazo[1,2-a]naphthyridinic systems 6a-15a and 6b-15b were obtained from Friedländer's reaction in imidazo[1,2-a]pyridine series. Most of the compounds were evaluated for their antitumor activity in the NCIs in vitro human tumor cell line screening panel. Among them, pentacyclic derivatives 13b and 14a exhibited in vitro activity comparable to anticancer agent such as amsacrine. Their mechanism of cytotoxicity action was unrelated to poisoning or inhibiting abilities against topo1. On the contrary, we highlighted a direct intercalation of the drugs into DNA by electrophoresis on agarose gel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18403058     DOI: 10.1016/j.ejmech.2008.02.017

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  3 in total

1.  Spectroscopic Studies on the Interaction of Naphthyridines with DNA and Fluorescent Detection of DNA in Agarose Gel.

Authors:  G Mahalakshmi; B Selvakumar; K N Vennila; P Lakshmana Rao; S Madhuri; M Seenivasaperumal; Kuppanagounder P Elango
Journal:  J Fluoresc       Date:  2021-01-03       Impact factor: 2.217

Review 2.  Fused 1,5-Naphthyridines: Synthetic Tools and Applications.

Authors:  Carme Masdeu; Maria Fuertes; Endika Martin-Encinas; Asier Selas; Gloria Rubiales; Francisco Palacios; Concepcion Alonso
Journal:  Molecules       Date:  2020-07-31       Impact factor: 4.411

Review 3.  Recent developments in the chemistry of deoxyribonucleic acid (DNA) intercalators: principles, design, synthesis, applications and trends.

Authors:  Brenno A D Neto; Alexandre A M Lapis
Journal:  Molecules       Date:  2009-05-07       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.